GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotron Ltd (ASX:BIT) » Definitions » Policy Acquisition Expense

Biotron (ASX:BIT) Policy Acquisition Expense


View and export this data going back to 2001. Start your Free Trial

What is Biotron Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Biotron (ASX:BIT) Business Description

Industry
Traded in Other Exchanges
Address
56 Delhi Road, Suite 3.3, North Ryde, Sydney, NSW, AUS, 2113
Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.